Biomedical Panel News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Biomedical Panel. Real-time updates on events, politics, business and more.

Resverlogix starts enrolment and dosing in Phase IIb Covid-19 therapy trial

January 19, 2022

Resverlogix has initiated enrolment and dosing in a Phase IIb trial of apabetalone (RVX-208) as a possible oral therapy to treat Covid-19.

Source: clinicaltrialsarena.com

November 2, 2021

Resverlogix is holding talks with the Ministry of Health of the Kingdom of Morocco to conduct Phase II trials of apabetalone for Covid-19.

Source: pharmaceutical-technology.com

October 12, 2021

Study Approval Paves the Way for Trial Participants to Begin Taking Apabetalone...

Source: globenewswire.com

October 12, 2021

Study Approval Paves the Way for Trial Participants to Begin Taking Apabetalone

Source: leaderpost.com